In this study, the authors reported statistically significant changes in cholesterol, triglycerides, fasting glucose and HbA1c, as well as shifts in oxidative and inflammation-related markers.

This randomized, placebo-controlled trial examined adults with metabolic syndrome over a 24-week period. Participants consumed hydrogen-rich water or placebo daily. Researchers measured changes in blood lipids, glucose-related markers, oxidative indicators and inflammation-related markers.

The authors reported the following numerical changes in the hydrogen-rich water group over the 24-week period:

• Total cholesterol: decreased by 18.5 mg/dL
  ≈ 9.9% reduction
• Triglycerides: decreased by 47 mg/dL
  ≈ 24.9% reduction
• Fasting blood glucose: decreased from 121.5 mg/dL to 103.1 mg/dL
  ≈ 15.1% reduction
• Hemoglobin A1c (HbA1c): decreased by ~12% (as reported by the authors)

In this study, the authors reported that these changes were statistically significant (P < 0.05).

Oxidation-related markers (MDA and d-conjugate) also decreased, while vitamins E and C increased. TNF-α, IL-6 and CRP were also reported to be reduced in the hydrogen group (P < 0.05). All outcomes except TBARS (P = 0.309) differed from placebo in this trial.

Researchers monitor these markers because they help identify trends in blood lipids, glucose regulation, oxidative processes and inflammation pathways. These indicators can shift due to many factors, including diet, physical activity, stress and intervention strategies. In this trial, the reported values reflect the specific study design, population and measurement methods.

Important Note

These results describe outcomes from this single research study. They are not general health claims and do not describe the effects of any product.

In this study, the authors reported statistically significant differences in blood lactate values and muscle soreness between the hydrogen-rich water condition and placebo, along with changes in exercise-related performance markers.

This randomized, double-blind, placebo-controlled cross-over trial included 12 men (mean ± SD age 23.8 ± 1.9 years).

Participants consumed 1,260 mL of hydrogen-rich water or placebo before resistance training.

Researchers measured set completion time, blood lactate, ratings of perceived exertion, creatine kinase, muscle soreness (VAS), countermovement jump and heart rate variability at baseline and at 30 minutes, 6 hours and 24 hours of recovery.

Mid-way through the session:

• Hydrogen-rich water group: 5.3 mmol/L
• Placebo group: 6.5 mmol/L

Difference: −1.2 mmol/L (p ≤ 0.008)

This number shows the hydrogen group had lower lactate values at that point in the test.

Immediately after the session:

• Hydrogen-rich water group: 5.1 mmol/L
• Placebo group: 6.3 mmol/L

Difference: −1.2 mmol/L (p ≤ 0.008)

This shows a similar difference right after the exercise was completed.

Muscle soreness (24 hours later):

• Hydrogen-rich water group: 26 mm
• Placebo group: 41 mm

Difference: −15 mm (p = 0.002)

These values reflect the soreness scores the participants recorded on a visual scale.

Set completion time (lunges):

The hydrogen-rich water group completed the lunge set in less time than placebo. (p < 0.001) Numerical values were not provided in the published summary.

The authors reported that all of these differences were statistically significant within the conditions tested.

Researchers track markers such as blood lactate, perceived soreness and set completion time to observe trends related to fatigue, effort and recovery in exercise studies. These values can shift due to training load, hydration, supplementation, recovery strategies and individual differences. In this trial, the reported values reflect the specific protocol, population and measurement methods.

Important Note

These results describe outcomes from this single research study. They are not general health claims and do not describe the effects of any product.

In this study, the authors reported statistically significant differences in several exercise-related markers between the hydrogen-rich water condition and placebo during aerobic and anaerobic testing.

This randomized, double-blind, placebo-controlled crossover trial included 22 male middle-distance runners. Participants consumed hydrogen-rich water or placebo before completing aerobic and anaerobic exercise tests. Researchers measured maximum aerobic speed (MAS), time to exhaustion, blood lactate, heart-rate responses and ratings of perceived exertion during exercise.

Maximum Aerobic Speed (MAS):

• Hydrogen-rich water condition: 16.9 ± 0.4 km/h
• Placebo condition: 16.5 ± 0.5 km/h

Difference: +0.4 km/h (p < 0.01)

These values reflect the running speeds recorded at the termination point of the aerobic test. 

Time to Exhaustion:

• Hydrogen-rich water condition: 13.3 ± 2.0 minutes
• Placebo condition: 12.2 ± 1.8 minutes

Difference: +1.1 minutes (p < 0.01)

This shows the recorded time participants maintained the final exercise stage before stopping.

Anaerobic Power Output (W/kg):

• Hydrogen-rich water condition: 7.35 ± 0.47
• Placebo condition: 7.04 ± 0.39

Difference: +0.31 W/kg (p < 0.05)

These were the measured power outputs during the anaerobic portion of the test.

Blood Lactate at 3 minutes post-exercise:

• Hydrogen-rich water condition: 11.4 ± 0.5 mmol/L
• Placebo condition: 12.2 ± 0.6 mmol/L

Difference: −0.8 mmol/L (p < 0.05)

This reflects lactate levels measured shortly after anaerobic exertion. 

Perceived Exertion (RPE):

Hydrogen-rich water condition: lower RPE scores reported (p < 0.05). Numerical values were not provided in the summary, but the authors reported the direction and statistical significance. 

The authors reported that these differences were statistically significant within the conditions tested.

Researchers use markers such as maximum aerobic speed, time to exhaustion, blood lactate and subjective exertion scores to observe physical performance responses during aerobic and anaerobic exercise. These metrics can shift due to effort level, hydration, pacing, supplementation and test design. In this study, the reported values show how these indicators changed between the two conditions under the specific experimental protocol.

Important Note

These results describe outcomes from this single research study. They are not general health claims and do not describe the effects of any product.